2002
Health services #66 Access to psychiatric services in new york city following the septemer 11th terrorist attacks
Boscarino J, Galea S, Ahern J, Resnick H, Vlahov D. Health services #66 Access to psychiatric services in new york city following the septemer 11th terrorist attacks. Annals Of Epidemiology 2002, 12: 514. DOI: 10.1016/s1047-2797(02)00354-x.Peer-Reviewed Original ResearchMental health visitsPosttraumatic stress disorderCurrent posttraumatic stress disorderMajor depressionHealth visitsPsychiatric medicationsHealth servicesCurrent major depressionMental health servicesYear oldsCommunity mental healthDial telephone surveyMedication utilizationMDS casesPsychiatric servicesMedicationsPanic attacksStress disorderMental healthAdult residentsVisitsTelephone surveyHealth insuranceAdequate accessPost-disaster treatment
2001
Longitudinal Study of Condom Use Patterns Among Women With or at Risk for HIV
Moore J, Hamburger M, Vlahov D, Schoenbaum E, Schuman P, Mayer K. Longitudinal Study of Condom Use Patterns Among Women With or at Risk for HIV. AIDS And Behavior 2001, 5: 263-273. DOI: 10.1023/a:1011344727416.Peer-Reviewed Original ResearchUninfected womenCondom use patternsConsistent condom useCondom useInfected partnerInfected womenSafe sex counselingUninfected male partnersInconsistent condom useLongitudinal studyGreater condom useHIV infectionActive HIVHIV serostatusUnknown serostatusPartner serostatusUninfected partnersStudy visitActive womenHIVSerostatusMale partnersWomenComparison groupVisitsNeedle-exchange participation, effectiveness, and policy: Syringe relay, gender, and the paradox of public health
Valente T, Foreman R, Junge B, Vlahov D. Needle-exchange participation, effectiveness, and policy: Syringe relay, gender, and the paradox of public health. Journal Of Urban Health 2001, 78: 340-349. PMID: 11419584, PMCID: PMC3456352, DOI: 10.1093/jurban/78.2.340.Peer-Reviewed Original ResearchMeSH KeywordsAdultBaltimoreCommerceCommunity Health PlanningCounselingFemaleHealth BehaviorHealth EducationHIV InfectionsHumansInterpersonal RelationsMaleMiddle AgedNeedle-Exchange ProgramsOrganizational ObjectivesProgram EvaluationSocial SupportSubstance Abuse, IntravenousSurveys and QuestionnairesSyringesUrban HealthConceptsNeedle exchange programsNEP useIntravenous drug usersBaltimore Needle Exchange ProgramPublic health goalsHIV seroconversionHIV protectionDrug usersHealth goalsVirus transmission rateHigh usersDuration of contactPublic healthEducation effortsCirculation timeMost studiesRelay activityExclusive useParticipantsSeroconversionHIVVisitsWomen
2000
Decline in Self-Reported High-Risk Injection-Related Behaviors Among HIV-Seropositive Participants in the Baltimore Needle Exchange Program
Vertefeuille J, Marx M, Tun W, Huettner S, Strathdee S, Vlahov D. Decline in Self-Reported High-Risk Injection-Related Behaviors Among HIV-Seropositive Participants in the Baltimore Needle Exchange Program. AIDS And Behavior 2000, 4: 381-388. DOI: 10.1023/a:1026406623736.Peer-Reviewed Original ResearchNeedle exchange programsHIV-seropositive drug usersDrug usersRisky drug use behaviorsHigh-risk injection practicesInjection-related behaviorsHIV-seropositive individualsHIV-seropositive participantsBaltimore Needle Exchange ProgramDrug use behaviorsNEP participantsDrug treatmentInjection practicesNEP attendanceMean numberVisitsT-testSignificant reductionExchange programsBaselineChi-square statisticsInjectionSyringesParticipantsFollow
1999
Pre-AIDS Mortality and Morbidity among Injection Drug Users in Amsterdam and Baltimore: An Ecological Comparison
van Ameijden E, Krol A, Vlahov D, Flynn C, van Haastrecht H, Coutinho R. Pre-AIDS Mortality and Morbidity among Injection Drug Users in Amsterdam and Baltimore: An Ecological Comparison. Substance Use & Misuse 1999, 34: 845-865. PMID: 10227114, DOI: 10.3109/10826089909037245.Peer-Reviewed Original ResearchMeSH KeywordsAdultAmphetaminesBaltimoreCause of DeathCocaineCohort StudiesComorbidityCost ControlCross-Cultural ComparisonDrug OverdoseEthanolFemaleHealth Services AccessibilityHeroinHIV SeropositivityHospitalizationHumansMaleMethadoneNetherlandsRisk FactorsSubstance Abuse, IntravenousSuicideSurvival RateUnited StatesConceptsDrug usersHigh-dose methadone maintenanceIncidence of hospitalizationSuicide mortalityEmergency room visitsInjection drug usersDifferent health care systemsHealth care systemHIV seropositivityRoom visitsHospital visitsMethadone maintenancePrimary careRecent injectingRisk factorsAIDS mortalityLower mortalityPolydrug useMortalityCare systemSocietal costsMorbidityVisitsHospitalizationBaltimore
1998
Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline
Markham R, Wang W, Weisstein A, Wang Z, Munoz A, Templeton A, Margolick J, Vlahov D, Quinn T, Farzadegan H, Yu X. Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline. Proceedings Of The National Academy Of Sciences Of The United States Of America 1998, 95: 12568-12573. PMID: 9770526, PMCID: PMC22871, DOI: 10.1073/pnas.95.21.12568.Peer-Reviewed Original ResearchConceptsCD4 T-cell declineT-cell declineCell declineHIV-1 env sequencesFirst seropositive visitModerate disease progressionCD4 T cellsInjection drug usersLow viral loadHIV-1 evolutionLater time pointsViral loadDisease progressionT cellsDrug usersPredominant virusNonsynonymous mutationsEnv sequencesTime pointsNonprogressorsTypes of mutationsDominant variantVisitsOnly quantitative differencesViral evolutionAssociation of Antibody to GB Virus C (Hepatitis G Virus) with Viral Clearance and Protection from Reinfection
Thomas D, Vlahov D, Alter H, Hunt J, Marshall R, Astemborski J, Nelson K. Association of Antibody to GB Virus C (Hepatitis G Virus) with Viral Clearance and Protection from Reinfection. The Journal Of Infectious Diseases 1998, 177: 539-542. PMID: 9498429, DOI: 10.1086/514245.Peer-Reviewed Original ResearchConceptsInjection drug usersGBV-C infectionGBV-C RNAViral clearanceGB virus C RNAPositive injection drug usersAssociation of antibodiesGB virus COngoing drug useEnvelope antibodiesRNA testingRNA clearanceDrug usersDrug useVirus CC RNADetectable RNAInfectionClearanceReinfectionPersistent RNAGBVAntibodiesRNAVisits
1997
Persistence and Clinical Significance of Hepatitis G Virus Infections in Injecting Drug Users
Thomas D, Nakatsuji Y, Shih J, Alter H, Nelson K, Astemborski J, Lyles C, Vlahov D. Persistence and Clinical Significance of Hepatitis G Virus Infections in Injecting Drug Users. The Journal Of Infectious Diseases 1997, 176: 586-592. PMID: 9291303, DOI: 10.1086/514078.Peer-Reviewed Original ResearchConceptsHepatitis G virus infectionG virus infectionHGV RNAHGV infectionVirus infectionDrug usersLiver-related enzymesRecent serum sampleInjecting Drug UsersHepatic inflammationAcute infectionSerum levelsLiver diseaseClinical significanceNegative participantsSerial samplesDrug useInfectionPrior visitSerum samplesIDUsPrior specimensRecent visitVisitsYears
1995
Medical Eligibility, Comprehension of the Consent Process, and Retention of Injection Drug Users Recruited for an HIV Vaccine Trial
Harrison K, Vlahov D, Jones K, Charron K, Clements M. Medical Eligibility, Comprehension of the Consent Process, and Retention of Injection Drug Users Recruited for an HIV Vaccine Trial. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1995, 10: 386-390. PMID: 7552502, DOI: 10.1097/00042560-199511000-00012.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAIDS VaccinesClinical Trials as TopicComprehensionConsent FormsDouble-Blind MethodEducational StatusEligibility DeterminationFemaleHIV InfectionsHumansInformed ConsentMaleMiddle AgedPatient SelectionResearch DesignResearch SubjectsSubstance Abuse, IntravenousSurveys and QuestionnairesConceptsInjection drug usersHIV vaccine trialsVaccine trialsDrug usersHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionPhase II trialInformed consent procedureConsent proceduresII trialVirus infectionHigh riskMedical reasonsMedical eligibilityTrialsConsent processEnrollmentFollowInfectionFalse testVisitsFactors Associated with Initiation of Zidovudine in a Cohort of Injection Drug Users
Solomon L, Vlahov D, Astemborski J, Galai N, Graham N, Nelson K. Factors Associated with Initiation of Zidovudine in a Cohort of Injection Drug Users. Journal Of Drug Issues 1995, 25: 225-233. DOI: 10.1177/002204269502500115.Peer-Reviewed Original Research
1993
Detection of Human Immunodeficiency Virus Type 1 Infection by Polymerase Chain Reaction in a Cohort of Seronegative Intravenous Drug Users
Farzadegan H, Vlahov D, Solomon L, Muñoz A, Astemborski J, Taylor E, Burnley A, Nelson K. Detection of Human Immunodeficiency Virus Type 1 Infection by Polymerase Chain Reaction in a Cohort of Seronegative Intravenous Drug Users. The Journal Of Infectious Diseases 1993, 168: 327-331. PMID: 8335969, DOI: 10.1093/infdis/168.2.327.Peer-Reviewed Original ResearchConceptsSeronegative intravenous drug usersIntravenous drug usersHuman immunodeficiency virus type 1 (HIV-1) infectionVirus type 1 infectionType 1 infectionPolymerase chain reactionDrug usersHIV-1 infectionHIV-1 antibodiesChain reactionLarge cohortBlood specimensProviral DNAInfectionCohortPCR analysisPersonsSerologyFollowVisitsAntibodiesMonths